What is Bio-Rad Laboratories, Inc.'s EBITDA?

Bio-Rad Laboratories, Inc. (BIO.B) reported EBITDA of $80.9M in Q1 2026.

How has Bio-Rad Laboratories, Inc.'s EBITDA changed year-over-year?

Bio-Rad Laboratories, Inc.'s EBITDA increased by 21.1% year-over-year, from $66.8M to $80.9M.

Bio-Rad Laboratories, Inc. BIO.B EBITDA

EBITDA at other companies

AbbottABT

——

Becton, Dickinson and CompanyBDX

——

Thermo Fisher ScientificTMO

——

DanaherDHR

——

Agilent TechnologiesA

——

RevvityRVTY

——

Other financials

Income statement

See full

Revenue$592.1M+1.1%

Gross profit$309.4M+1.1%

Operating income$34.1M+43.9%

Net income-$527.1M-924%

EPS (diluted)-$19.55-954%

Balance sheet

See full

Cash & equivalents$509.0M-2.7%

Total debt$987.3M-28.4%

Total equity$6.9B+2.6%

Total assets$9.8B+2.8%

Cash flow

See full

Operating cash flow$108.1M-16.8%

CapEx$30.0M-12.8%

Free cash flow$78.1M-18.2%

Valuation

See full

Market cap$7.56B+10.3%

Enterprise value$8.04B+4.2%

P/E44.8×—

P/S2.9×+0.2×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin8.8%-3.1pp

Net margin6.5%+3.4pp

FCF margin13.8%-0.2pp

Returns & leverage

See full

Return on equity2.5%+1.3pp

Debt / equity0.1×-0.1×

Current ratio3.2×-2.8×

Where this comes from

Calculated from Bio-Rad Laboratories, Inc.’s reported figures.

$34.1Mebit+

$46.8MDepreciation Depletion & Amortization

=$80.9M

The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories, Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s EBITDA?: Bio-Rad Laboratories, Inc. (BIO.B) reported EBITDA of $80.9M in Q1 2026.
How has Bio-Rad Laboratories, Inc.'s EBITDA changed year-over-year?: Bio-Rad Laboratories, Inc.'s EBITDA increased by 21.1% year-over-year, from $66.8M to $80.9M.